260 related articles for article (PubMed ID: 16696581)
1. Zolpidem extended-release.
Moen MD; Plosker GL
CNS Drugs; 2006; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
6. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
8. Sublingual zolpidem (Edluar™; Sublinox™).
Yang LP; Deeks ED
CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
[TBL] [Abstract][Full Text] [Related]
9. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
[TBL] [Abstract][Full Text] [Related]
10. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
Sleep; 2011 Feb; 34(2):207-12. PubMed ID: 21286241
[TBL] [Abstract][Full Text] [Related]
11. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
12. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
Roehrs TA; Roth T
J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
[TBL] [Abstract][Full Text] [Related]
13. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
[TBL] [Abstract][Full Text] [Related]
14. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
[TBL] [Abstract][Full Text] [Related]
15. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
Barkin RL
Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
[TBL] [Abstract][Full Text] [Related]
16. Effects of Zolpidem CR on Sleep and Nocturnal Ventilation in Patients with Heart Failure.
Gatti RC; Burke PR; Otuyama LJ; Almeida DR; Tufik S; Poyares D
Sleep; 2016 Aug; 39(8):1501-5. PubMed ID: 27166233
[TBL] [Abstract][Full Text] [Related]
17. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.
Randall S; Roehrs TA; Roth T
Sleep; 2012 Nov; 35(11):1551-7. PubMed ID: 23115404
[TBL] [Abstract][Full Text] [Related]
19. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
20. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal.
Monti JM; Monti D; Estévez F; Giusti M
Int Clin Psychopharmacol; 1996 Dec; 11(4):255-63. PubMed ID: 9031992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
